Price
No data yet.
Social Signal Score
Analyst Ratings
2 analystsRevenue
$5.12MAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Paul Elliot Mann
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 271
- Beta
- 3.60
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- -0.23
Financials
Revenue
$5.12M+1083.1%Net Income
$-33.59MEBITDA
$-32.99MFree Cash Flow
$-27.42MEPS (diluted)
$-0.27Shares Outstanding (diluted)
122.72M+257.2%Operating Expenses
$35.67MCash & Debt
$254.90MRevenue by Segment (annual)
$23.85MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $23.85M | $-175.09M | $-2.11 |
| 2024 | $4.14M | $-32.33M | $-0.63 |
| 2023 | $433.0K | $-16.29M | $-0.49 |
| 2022 | $0.00 | $-4.95M | $-0.13 |
| 2021 | $0.00 | $-2.61M | $-0.08 |
| 2019 | $22.63M | $-10.26M | $-0.30 |
Valuation
ASPIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120-7.69%Social Signal Score
Mentions (5)
- Newsseekingalpha.com·27d ago·Positive
ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript
View source ↗ - Newsglobenewswire.com·28d ago·Positive
ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update DALLAS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for critical materials production, today hosts its inaugural Capital Markets Day in London. Management will outline the Company's strategy across nuclear medicine, electronics, helium and LNG, and nuclear fuels, and will provide …
View source ↗ - Newsmarketbeat.com·45d ago·Neutral
ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth ASP Isotopes NASDAQ: ASPI expects several of its business units to enter commercial production or expand output over the next six months, with Chief Executive Officer Paul Mann highlighting progress in helium, liquefied natural gas, stable isotopes and radiopharmaceuticals during a conference presentation.
View source ↗ - Newsglobenewswire.com·47d ago·Negative
…. The Company is currently exploring ways to accelerate the revenues and cash flows from Phase 2 DALLAS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Tetra4 Proprietary Limited, a subsidiary of Renergen Limited (“Renergen”) and the developer of the Virginia Gas Project, ha…
View source ↗ - Newsmarketbeat.com·55d ago·Positive
ASP Isotopes Targets 2026 Deliveries as Helium, Radiopharmacy Expansion Gains Speed ASP Isotopes NASDAQ: ASPI outlined plans to expand its isotope production, radiopharmacy and helium businesses during Canaccord Genuity's 46th Annual Growth Conference, with commercial deliveries of several stable isotopes targeted for the second half of 2026.
View source ↗
Earnings
Thu, Nov 12(in 5 weeks)
Consensus estimate $-0.15 per share
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 14$-0.28 vs $-0.17miss
- Wed, May 20$-0.06 vs $-0.06beat
- Fri, Apr 10$-0.84 vs $-0.10miss
- Wed, Nov 19$-0.15 vs $-0.15beat
- Thu, Aug 14$-1.03 vs $-1.03beat
- Tue, May 20$-0.12 vs $-0.12beat
Estimates and results for ASPI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ASPI officers and directors.
- Bought
- $513k
- Sold
- $19.9m
6 trades
43 trades
- Ryan Robert John Andrewbought
- Ryan Robert John Andrewbought
- Ainscow Robertsold
- Mann Paul Elliotsold
- Mann Paul Elliotsold
- Ainscow Donald Georgesold
- Ainscow Robertsold
- Mann Paul Elliotsold
51 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ASPI.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.